Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$2,958,531
+$403,459 QoQ
Shares Held
11,757
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#1,662
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bedel Financial Consulting, Inc. holds $404,013,991 across 11 Drug Manufacturers - General names. ABBV ranks #3 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
328,198 | $393,650,559 | |
| 2 | JNJ |
Johnson & Johnson
|
13,084 | $3,322,943 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
11,757 | $2,958,531 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,015 | $901,427 | |
| 5 | PFE |
Pfizer Inc
|
31,588 | $760,639 | |
| 6 | NVS |
Novartis AG
|
4,326 | $677,970 | |
| 7 | AMGN |
Amgen Inc
|
1,648 | $596,773 | |
| 8 | GSK |
GSK plc
|
7,562 | $396,400 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,958,531 | 11,757 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $2,555,072 | 11,748 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,678,816 | 11,724 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $2,916,709 | 12,597 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,332,686 | 12,567 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,628,218 | 12,544 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,217,162 | 12,477 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,429,398 | 12,302 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,104,035 | 12,267 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $2,230,542 | 12,249 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,908,455 | 12,315 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,882,478 | 12,629 | Shares | Sole | 2024-02-08 | |
| 2023-06-30 | $1,688,840 | 12,535 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,973,319 | 12,382 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,017,862 | 12,486 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,636,690 | 12,195 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,862,578 | 12,161 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,939,484 | 11,964 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $1,571,723 | 11,608 | Shares | Other | 2022-01-11 | |
| 2021-09-30 | $1,198,867 | 11,114 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $1,046,538 | 9,291 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $946,383 | 8,745 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $844,342 | 7,880 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $644,224 | 7,355 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $740,866 | 7,546 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $622,091 | 8,165 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||